Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2025-07-24 Board/Management Inform…
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
Board/Management Information Classification · 100% confidence The document is a press release dated July 23, 2025, announcing the appointment of two new senior executives (Chief Business Officer and Chief Strategy Officer) and detailing their roles and backgrounds. This content directly relates to changes in the company's senior management team. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is clearly an announcement of management changes, not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A).
2025-07-24 Dutch
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of two new senior executives (Chief Business Officer and Chief Strategy Officer) to the leadership team, effective August 4, 2025. This content directly relates to changes in the company's senior management structure. Based on the provided definitions, the category 'Board/Management Information (Code: MANG)' is the most appropriate fit, as it covers 'Announcement of changes in the company's board of directors or senior management.' The document is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2025-07-24 English
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors
Board/Management Information Classification · 100% confidence The document is a press release dated July 23, 2025, announcing the appointment of two new Non-Executive Independent Directors to the Board of Directors of Galapagos NV. This content directly relates to changes in the company's board structure and senior personnel. According to the definitions, the 'Board/Management Information (Code: MANG)' category covers the 'Announcement of changes in the company's board of directors or senior management.' The document is not a full financial report (10-K, IR), a dividend notice (DIV), or a proxy statement (DEF 14A/PSI). Therefore, MANG is the most appropriate classification.
2025-07-24 English
Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoronos en Jane Griffiths in haar Raad van Bestuur
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of two new independent non-executive directors to the Board of Directors of Galapagos NV. It details the professional backgrounds of the new appointees and mentions the departure of two existing board members. This content falls squarely under the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-07-24 Dutch
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive financial announcement from Galapagos NV detailing their half-year 2025 financial results. It includes key financial figures, a detailed breakdown of operating losses, revenues, R&D expenses, and business updates. While it mentions that a full report is available on their website, the document itself contains substantive financial data and analysis for the six-month period, qualifying it as an Interim/Quarterly Report (IR) rather than just a publication announcement. H1 2025
2025-07-24 English
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
Earnings Release Classification · 100% confidence The document is titled "Galapagos rapporteert halfjaarcijfers 2025 en geeft een update over de activiteiten in het tweede kwartaal" (Galapagos reports half-year figures 2025 and provides an update on Q2 activities). It explicitly details "financiële resultaten voor het eerste halfjaar van 2025" (financial results for the first half of 2025) and includes a detailed table of "Kerncijfers eerste halfjaar 2025 (geconsolideerd)" (Key figures first half-year 2025 (consolidated)). This content structure, covering a six-month period with comprehensive financial data, clearly identifies it as a comprehensive interim financial report, which corresponds to the Interim / Quarterly Report category (IR). Although it contains operational updates, the core purpose is the reporting of half-year financial performance. H1 2025
2025-07-24 Dutch

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.